30 Turbo Cancer Treatment race is on: Johnson & Johnson just completed $2 billion cancer drug buy of Ambrx on March 7, 2024 - Merck, Novartis, Sanofi, Eli Lilly, AbbVie, Pfizer, BMS - they all want in! (twitter.com) posted 259 days ago by brain_dead 259 days ago by brain_dead +30 / -0 10 comments share 10 comments share save hide report block hide replies
What can and should happen here is mass promulgation of alternative cures KNOWN by we anons and let the pharma killers die on the vine. Now if Med Beds are availible, game changer too.